IPO News & Commentary
Get the latest insights on new stocks
- Cardiac medical device developer BioVentrix withdraws $17 million IPO 10/14/26
- Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO 10/14/26
- IPO Weekly Weigh-in: Why investors said no to this $3.5B AI IPO 10/14/26
- SPAC Hall Chadwick Acquisition II lowers deal size by 25% ahead of $200 million IPO 10/13/26
- SPAC EuroSPAC Acquisition files for a $125 million US IPO, led by the CEO of Euroseas 10/13/26
- SPAC Apex Treasury II files for a $250 million IPO, targeting AI infrastructure, energy, defense, and fintech 10/13/26
- Chinese executives' SPAC Creative Future Acquisition withdraws $60 million IPO 10/13/26
See more
IPO News By Industry
- Christian-focused connectivity firm Patriot Mobile files for a $10 million IPO 10/09/26
- Hong Kong-based marketing firm AM PM Group doubles shares offered ahead of $34 million US IPO 08/27/26
- Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO 08/06/26
NYSE IPO News
- IPO Weekly Weigh-in: Why investors said no to this $3.5B AI IPO 10/14/26
- Emerging markets fintech OPay files for an estimated $500 million US IPO 10/09/26
- Cavity treatment provider vVardis files for an estimated $200 million US IPO 10/09/26
- SPAC Calm Seas Acquisition lowers units offered by 25% ahead of $200 million IPO 10/08/26
- Spinal implant developer Centinel Spine files for a $100 million IPO 10/07/26
Nasdaq IPO News
- Small molecule biotech Iambic Therapeutics prices IPO at $16, the midpoint of the range 10/15/26
- Metal powder producer Amaero prices downsized US IPO at $4.25 per share 10/14/26
- Cardiac medical device developer BioVentrix withdraws $17 million IPO 10/14/26
- Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO 10/14/26
- SPAC Hall Chadwick Acquisition II lowers deal size by 25% ahead of $200 million IPO 10/13/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
Small molecule biotech Iambic Therapeutics prices IPO at $16, the midpoint of the range
Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, raised $150 million by offering 9.4 million shares at $16, within the $15 to $17 range. Existing shareholder ARK Investment Management and new investor...read more
Metal powder producer Amaero prices downsized US IPO at $4.25 per share
Amaero, a producer of titanium and refractory metal powders for defense and aerospace 3D printing, raised $20 million in its Nasdaq cross-listing by offering 4.7 million shares at $4.25. That is slightly below the converted last-close of its shares on the...read more
Tungsten Miners Weigh IPOs Following Price Surge
Tungsten prices have soared over the past two years amid supply constraints, spurring miners to tap public markets. Two private tungsten miners flagged IPO plans last week, following the US IPO of Guardian Metal Resources in March. Tungsten is a hard,...read more